Skip to main content
CONTEC MEDICAL SYSTEMS CO., LTD. logo

CONTEC MEDICAL SYSTEMS CO., LTD. — Investor Relations & Filings

Ticker · 300869 ISIN · CNE1000047F0 LEI · 6556007SL3V6YKCWVA55 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 789 across all filing types
Latest filing 2021-09-27 Director's Dealing
Country CN China
Listing Shenzhen Stock Exchange 300869

About CONTEC MEDICAL SYSTEMS CO., LTD.

https://www.contecmed.com.cn

CONTEC Medical Systems Co., Ltd. focuses on the research, development, manufacturing, and distribution of medical electronic instruments. The product portfolio encompasses a wide range of diagnostic and monitoring solutions, including pulse oximeters, blood pressure monitors, electrocardiographs, ultrasound equipment, and multi-parameter patient monitors. Additionally, the company provides specialized devices such as fetal monitors, sleep apnea screening systems, and biochemical analyzers. By leveraging integrated research and large-scale production facilities, the organization delivers medical technology designed for clinical, hospital, and home healthcare environments. The company emphasizes technical innovation and adheres to international quality standards to ensure the precision and reliability of its medical hardware and software solutions.

Recent filings

Filing Released Lang Actions
关于公司部分高级管理人员减持计划减持数量过半的进展公告
Director's Dealing Classification · 100% confidence The document is an announcement regarding the progress of a shareholding reduction plan by a senior management member, Liu Zhenhong, including details of shares sold, prices, and compliance with relevant securities regulations. It does not contain financial statements or detailed financial performance data. It is a notification about insider share transactions by a company director or senior executive. Therefore, it fits the category of Director's Dealing (DIRS). The document length is short and focused on share transactions by management, confirming this classification.
2021-09-27 Chinese
关于公司签署国有建设用地使用权出让合同的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the signing of a state-owned construction land use right transfer contract by the company. It details the transaction overview, contract parties, land location, usage, price, payment terms, and the impact on the company. There is no financial data or report content, but rather a disclosure of a specific transaction related to land acquisition. This fits the category of Capital/Financing Update (CAP), as it involves a significant capital asset acquisition and related financing details. The document length is short and focused on this transaction, not a full financial report or other types of filings.
2021-09-24 Chinese
2021年第二次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 2021 second extraordinary general meeting of shareholders of 康泰医学系统（秦皇岛）股份有限公司. It includes voting results on various proposals related to the issuance of convertible bonds, meeting attendance, and legal opinions confirming the validity of the meeting and resolutions. The content is focused on the official voting results and decisions made by shareholders at the meeting, rather than the full report or detailed financial data. The document length is over 12,000 characters, indicating it is not a brief notice but a full announcement of voting results. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2021-09-07 Chinese
北京市长安律师事务所关于康泰医学2021年第二次临时股东大会之法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the 2021 second extraordinary general meeting (临时股东大会) of 康泰医学系统（秦皇岛）股份有限公司. It details the convening, attendance, voting procedures, and results of the shareholders' meeting, including approval of various proposals related to convertible bonds issuance. The document is not the meeting notice or a brief announcement but a detailed legal opinion on the meeting's legality and voting results. This type of document is best classified as Declaration of Voting Results & Voting Rights Announcements (DVA), as it provides official voting results and legal confirmation of the meeting proceedings and outcomes.
2021-09-07 Chinese
申万宏源证券承销保荐有限责任公司关于康泰医学系统（秦皇岛）股份有限公司2021年半年度跟踪报告
Regulatory Filings Classification · 95% confidence The document is titled as a '2021 Half-Year Tracking Report' by a sponsoring securities company regarding a specific company. It details the sponsor's review and supervision activities, compliance with regulations, and company commitments during the half-year period. The content focuses on oversight, compliance, and monitoring rather than presenting comprehensive financial statements or detailed financial analysis. The document length is 2098 characters, which is relatively short and more consistent with a monitoring or tracking report rather than a full interim or annual report. It does not contain actual financial statements or substantive financial data typical of an Interim/Quarterly Report (IR). Instead, it is a report on the sponsor's tracking and supervision work for the half-year period. This type of document aligns best with the category of Regulatory Filings (RNS), which includes compliance documents and miscellaneous filings that do not fit other categories. Therefore, the appropriate classification is Regulatory Filings (RNS).
2021-09-06 Chinese
股票交易异常波动公告
Regulatory Filings Classification · 95% confidence The document is a stock trading abnormal fluctuation announcement by 康泰医学系统（秦皇岛）股份有限公司. It discusses the stock price drop over three consecutive trading days, the company's investigation into the cause, and confirms no undisclosed material information exists. The document is short (1338 characters) and serves as a regulatory disclosure about stock price movement and compliance with disclosure rules. It does not contain financial statements, management discussion, or detailed financial data. It is not an annual or interim report, earnings release, or any detailed financial report. It is a regulatory announcement about stock price abnormality and compliance, fitting the category of Regulatory Filings (RNS).
2021-08-25 Chinese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.